{"sections": 
    [
        {
            "step":1,
            "name":"Problem formulation",
            "description": "Detailed description of the study objectives and expected outcomes, including expected used for decision making and acceptable uncertainty levels.",
            "subsections": [
                {"step": null,
                "name":"Scope",
                "description": "e.g. human allowable exposures in health risk assessment, prioritization, screening, classification and labelling. Indicate also which data gaps are to be filled by the RAx.",
                "subsections": [],
                "type": "free-text",
                "field": "scope"
                },
                {"step": null,
                    "name":"Decision context",
                    "description": "Describe the regulatory context, data requirements and the testing strategy.",
                    "subsections": [],
                    "type": "free-text",
                    "field": "decision_context"
                },
                {"step": null,
                    "name":"Endpoints",
                    "description": "Endpoints to study.",
                    "subsections": [],
                    "type": "free-text",
                    "field": "endpoints"
                },
                {"step": null,
                    "name":"Tolerable uncertainty threshold",
                    "description": "Tolerable uncertainty threshold for Read-Across results a according to the regulatory context",
                    "subsections": [],
                    "type": "free-text",
                    "field": "uncertainty"
                },
                {"step": null,
                    "name":"Comments",
                    "description": null,
                    "subsections": [],
                    "type": "free-text",
                    "field": "node-comments"
                }
            
            ]
        },
        {
            "step":2,
            "name":"TC Characterization",
            "description": "Describe the Target Compound: TC structure (SMILES, InChiKey), IDs (CAS-RN, PubChemID, ChEMBL, ID) and gather any relevant biological information from bibliographic data sources or relevant in silico prediction models",
            "subsections": [
                {"step": null,
                "name":"Target compounds",
                "description": null,
                "subsections": [],
                "type": "compound",
                "field": "compounds"
                },
                {"step": null,
                    "name":"Comments",
                    "description": null,
                    "subsections": [],
                    "type": "free-text",
                    "field": "node-comments"
                }
            
            ]
        },
        {
            "step":3,
            "name":"Initial RAX hypothesis",
            "description": "Explain your initial RAX strategy.",
            "subsections": [
                {"step": null,
                "name":"Analogue/Category approach",
                "description": "Justify the analogue/category approach.",
                "subsections": [],
                "type": "free-text",
                "field": "ana_cat_approach"
                },
                {"step": null,
                    "name":"Metabolism role in Read-Across",
                    "description": "Describe relevance of metabolism of the target compound (TC), its metabolites and similarities between TC and source compound metabolites.",
                    "subsections": [],
                    "type": "free-text",
                    "field": "metabolism"
                },
                {"step": null,
                    "name":"Approach justification",
                    "description": "e.g. similarity, regular pattern or worst-case relationship between TC and analogues or categories. Justify the approach taken.",
                    "subsections": [],
                    "type": "free-text",
                    "field": "quantitative_var_approach"
                },
                {"step": null,
                    "name":"Comments",
                    "description": null,
                    "subsections": [],
                    "type": "free-text",
                    "field": "node-comments"
                }
            
            ]
        },
        {
            "step":4,
            "name":"SC Identification",
            "description": "SC identification by the initial RAX hypothesis.",
            "subsections": [
                {"step": null,
                "name":"Source compounds",
                "description": null,
                "subsections": [],
                "type": "compound",
                "field": "compounds"
                },
                {"step": null,
                    "name":"PhysicoChemical Properties",
                    "description": null,
                    "subsections": [],
                    "type": "datatable",
                    "field": "pc"
                },
                {"step": null,
                    "name":"Comments",
                    "description": null,
                    "subsections": [],
                    "type": "free-text",
                    "field": "node-comments"
                }
            
            ]
        },
        {
            "step": null,
            "name":"Appendix: TC Physicochemical, ADME and Toxicity data",
            "description": "SC identification by the initial RAX hypothesis.",
            "subsections": [
                {"step": null,
                "name":"Appendix: TC Physicochemical, ADME and Toxicity data",
                "description": null,
                "subsections": [],
                "type": "datamatrix_single",
                "field": "tc_data"
                }
            
            ]
        }
    ]
}